Incidence of Polypharmacy in Type 2 Diabetic Patients in a Rural Tertiary Care Teaching Hospital in South India



  • Renukaradhya Chitti
  • Kumaraswamy M
  • Ankit Acharya
  • Vijay C H
  • Keshav Dhakal
  • Madan Rayamajhi
  • Azad Moidul Islam
  • Faruk Azad Kibria


Type 2 diabetes mellitusis a serious metabolic disorder with high prevalence rate throughout the world, especially in India. Due to the co-morbid conditions, there is necessity of polypharmacy among diabetes patients. The objective of this study was to assess the incidence of polypharmacy in type-2 diabetic patients admitted to general medicine units in a typical tertiary hospital in India. A prospective and observational study was conducted among type-2 diabetic inpatients for the period of 9 months. A total of 152 patients were enrolled; female 90 (59%) patients predominated over males 62 (41%) patients. Maximum participants were illiterate (65%) from very low income families (58%). Out of 152 patients, 128 (84%) patients experience polypharmacy as part their treatment regimen. Polypharmacy was noted with a range of 4 to 8 drugs per prescription. In patients with age group of 51-60, 61-70 and 70 above, including females, smokers, alcohol users, co-morbidity was positively associated with polypharmacy, indicating that diabetes is associated with a variety of other conditions.   



Download data is not yet available.


Metrics Loading ...


Diabetes mellitus, Polypharmacy, Co-morbidity, type-2 diabetes




How to Cite

Chitti R, M K, Acharya A, C H V, Dhakal K, Rayamajhi M, et al. Incidence of Polypharmacy in Type 2 Diabetic Patients in a Rural Tertiary Care Teaching Hospital in South India. Scopus Indexed [Internet]. 2017 Nov. 30 [cited 2024 Jun. 20];10(6):3906-8. Available from:



Research Articles


Antonelli IR, Corsonelli F and Pedone C (2005). Depression and drug utilization in an older population. Ther Clin Risk Manag 1: 55-60.
Ayesha R, Laxminarayana K, Astha S, Sushma M and Jayanthi CR (2012). Poly pharmacy leading to adverse drug reactions in elderly in a tertiary care hospital. Int J Pharm Bio Sci 3(3): 218-24.
Choe HM, Mitrovich S and Dubay D (2005). Proactive case management of high-risk patients with Type-2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Managed Care 11: 253-60.
Hajjar ER, Cafiero AC and Hanlon JT (2007). Poly pharmacy among elderly patients. Am J Geriatr Pharmacother 5: 345-51.
Hilmer SN (2008). The dilemma of polypharmacy. Aust Pres 31: 2-3.
Mohan V, Sandeep S, Deepa R, Shah B and Varghese C (2007). Epidemiology of Type-2 diabetes: Indian scenario. Ind J Med Res 125(3): 217-30.
Ong KL, Cheung BM, Wong LY, Wat NM, Tan KC and Lam KS (2008). Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey. 1999-2004. Ann Epidemiol. 18: 222-29.
Srivastsa S, Bose D, Sushma M and Jayanthi CR (2016). A prospective cohort study to evaluate the correlates of poly pharmacy and its association with depression among elderly patients. Int J Basic Clin Pharmaco 5(5): 1984-90.